Lexaria Bioscience hires Integra Consulting for investor relations services

() (OTCMKTS:LXRP) has hired Integra Consulting Group to provide investor relations (IR) services to the company.

Integra will work with the firm to communicate its message to maximize corporate visibility, will seek out opportunities to deliver audience-targeted presentations, and will use web-casting to reach bigger audiences.

READ: Lexaria Bioscience trumpets its slate of DehydraTECH licensing agreements

Integra is being hired for an initial six-month contract and will receive US$12,500 per month and a total of 150,000 company shares.

Lexaria has developed and out-licenses a technology that promotes healthier ingestion methods.

Earlier this week, the group said it had inked 11 licensing agreements for its DehydraTECH drug absorption platform thus far in 2019.

Broadly, DehydraTECH helps nutrients and pharmaceutical ingredients get absorbed faster and more effectively by the body.

Lexaria’s licensees are using it to create things like cannabis edibles, CBD beverages and oral nicotine products.